Get the Stockscreener App
4.83
0.41%
-0.02
Recursion Pharmaceuticals Inc stock is traded at $4.83, with a volume of 16.97M.
It is down -0.41% in the last 24 hours and down -10.72% over the past month.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
See More
Previous Close:
$4.85
Open:
$4.96
24h Volume:
16.97M
Relative Volume:
0.70
Market Cap:
$2.06B
Revenue:
$64.60M
Net Income/Loss:
$-377.75M
P/E Ratio:
-3.1161
EPS:
-1.55
Net Cash Flow:
$-335.64M
1W Performance:
+4.77%
1M Performance:
-10.72%
6M Performance:
-21.72%
1Y Performance:
-25.69%
1-Day Range:
$4.80
$5.00
1-Week Range:
$4.51
$5.05
52-Week Range:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Name
Recursion Pharmaceuticals Inc
Sector
Industry
Phone
(385) 269-0203
Address
41S RIO GRANDE STREET, SALT LAKE CITY
Compare RXRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
4.83 | 1.98B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-22-23 | Initiated | Morgan Stanley | Equal-Weight |
| Mar-16-23 | Initiated | Needham | Buy |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-18-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-21-21 | Initiated | Berenberg | Buy |
| May-11-21 | Initiated | BofA Securities | Buy |
| May-11-21 | Initiated | Goldman | Neutral |
| May-11-21 | Initiated | JP Morgan | Neutral |
| May-11-21 | Initiated | KeyBanc Capital Markets | Overweight |
| May-11-21 | Initiated | SVB Leerink | Outperform |
View All
Recursion Pharmaceuticals Inc Stock (RXRX) Latest News
Recursion Pharmaceuticals, Inc. $RXRX Shares Purchased by Advisors Asset Management Inc. - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading 8.7% HigherHere's What Happened - MarketBeat
Recursion Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Is Recursion Pharmaceuticals (NASDAQ:RXRX) Using Debt In A Risky Way? - 富途牛牛
Recursion Pharmaceuticals Stock: An Exponential Climb? - timothysykes.com
Will Recursion Pharmaceuticals Rise or Fall? - StocksToTrade
RXRX’s Market Strategy: Analyzing Recent Developments - timothysykes.com
Oversold Conditions For Recursion Pharmaceuticals (RXRX) - Nasdaq
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia - MSN
Russell Investments Group Ltd. Has $206,000 Stock Position in Recursion Pharmaceuticals, Inc. $RXRX - MarketBeat
Is Recursion Pharmaceuticals Inc. forming a breakout patternJuly 2025 Big Picture & AI Forecast for Swing Trade Picks - beatles.ru
Ranking Recursion Pharmaceuticals Inc. among high performing stocks via toolsSwing Trade & Daily Price Action Insights - Newser
Recursion Pharmaceuticals Stock (RXRX) Opinions on AI-Driven Pipeline Updates - Quiver Quantitative
Tools to assess Recursion Pharmaceuticals Inc.’s risk profileJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Published on: 2025-09-08 04:20:29 - Newser
Applying Wyckoff theory to Recursion Pharmaceuticals Inc. stockQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Recursion Pharmaceuticals Inc. technicalsEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Analyzing recovery setups for Recursion Pharmaceuticals Inc. investors2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
Real time alert setup for Recursion Pharmaceuticals Inc. performanceBond Market & Free Community Consensus Stock Picks - Newser
Detecting support and resistance levels for Recursion Pharmaceuticals Inc.CEO Change & High Win Rate Trade Tips - Newser
Multi asset correlation models including Recursion Pharmaceuticals Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
How to read the order book for Recursion Pharmaceuticals Inc.Market Weekly Review & Verified Swing Trading Watchlist - Newser
Will Recursion Pharmaceuticals Inc. stock recover after recent drop2025 Technical Patterns & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of Recursion Pharmaceuticals Inc. visualizedGold Moves & Weekly Chart Analysis and Guides - Newser
Volatility clustering patterns for Recursion Pharmaceuticals IncJuly 2025 Breakouts & High Yield Equity Trading Tips - Newser
Chart based exit strategy for Recursion Pharmaceuticals Inc.2025 Institutional Moves & Real-Time Volume Analysis - Newser
Recursion Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Can Recursion Pharmaceuticals Inc. rally from current levels2025 Price Momentum & AI Forecasted Entry and Exit Points - Newser
How to escape a deep drawdown in Recursion Pharmaceuticals Inc.Portfolio Return Report & Free Expert Approved Momentum Trade Ideas - Newser
S P Trends: Will Recursion Pharmaceuticals Inc. outperform tech stocksRecession Risk & Technical Entry and Exit Alerts - خودرو بانک
What’s the recovery path for long term holders of Recursion Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Strategies - Newser
Will Recursion Pharmaceuticals Inc. see short term momentumIPO Watch & Real-Time Chart Pattern Alerts - Newser
Will Recursion Pharmaceuticals Inc. benefit from current market trends2025 Risk Factors & High Accuracy Swing Trade Signals - خودرو بانک
Is Recursion Pharmaceuticals Inc. in a long term uptrendInsider Buying & Safe Capital Growth Trade Ideas - خودرو بانک
Will Recursion Pharmaceuticals Inc. benefit from macro trendsMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Applying chart zones and confluence areas to Recursion Pharmaceuticals Inc.2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Forecasting Recursion Pharmaceuticals Inc. price range with options dataWeekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Is Recursion Pharmaceuticals Inc. a strong growth stockJuly 2025 Trade Ideas & Consistent Growth Equity Picks - خودرو بانک
Tools to monitor Recursion Pharmaceuticals Inc. recovery probability2025 Volatility Report & AI Driven Stock Movement Reports - Newser
Can technical indicators confirm Recursion Pharmaceuticals Inc.’s reversalAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
Can Recursion Pharmaceuticals Inc. hit a new high this monthTrade Analysis Summary & Verified Entry Point Detection - Newser
Visualizing Recursion Pharmaceuticals Inc. stock with heatmapsJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Recursion Pharmaceuticals' Strategic Position in TechBio and Clinical Pipeline Progress - AInvest
Pattern recognition hints at Recursion Pharmaceuticals Inc. upsideLayoff News & Safe Entry Point Alerts - Newser
Is Recursion Pharmaceuticals Inc. trending in predictive chart models2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
Aug Update: What is the Moat Score of Recursion Pharmaceuticals Inc.Risk Management & Low Volatility Stock Suggestions - خودرو بانک
Technical analysis overview for Recursion Pharmaceuticals Inc. stockJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
How liquid is Recursion Pharmaceuticals Inc. stock2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - خودرو بانک
Can machine learning forecast Recursion Pharmaceuticals Inc. recoveryJuly 2025 Summary & Fast Momentum Entry Tips - Newser
Recursion Pharmaceuticals shares rise 1.93% premarket as AI-driven drug discovery gains traction. - AInvest
Recursion Pharmaceuticals Inc Stock (RXRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):